title: Clinically useful monoclonal antibodies in treatment.
abstract: Monoclonal antibodies have been used in clinical diagnosis for many years but it is only now that these agents are being licensed for clinical treatments. This review will focus on UK licensed monoclonal antibodies highlighting their clinical benefits, limitations, and side effects.
authors.affiliation: Clinical Immunology Unit, Queens Medical Centre, Nottingham NG7 2UH, UK. Liz.Drewe@Nottingham.AC.UK
authors.forename: E
authors.initials: E
authors.lastname: Drewe
authors.forename: R J
authors.initials: RJ
authors.lastname: Powell
mesh_terms: D000911:Antibodies, Monoclonal / Q000009:adverse effects / Q000627:therapeutic use*; D001172:Arthritis, Rheumatoid / Q000628:therapy; D003327:Coronary Disease / Q000628:therapy; D003424:Crohn Disease / Q000628:therapy; D006084:Graft Rejection / Q000517:prevention & control; D006801:Humans; D009369:Neoplasms / Q000628:therapy; D014777:Virus Diseases / Q000628:therapy
chemical_list: D000911:Antibodies, Monoclonal